Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 46

1.

Programmed disorders of beta-cell development and function as one cause for type 2 diabetes? The GK rat paradigm.

Portha B.

Diabetes Metab Res Rev. 2005 Nov-Dec;21(6):495-504. Review.

PMID:
15926190
[PubMed - indexed for MEDLINE]
2.

The GK rat beta-cell: a prototype for the diseased human beta-cell in type 2 diabetes?

Portha B, Lacraz G, Kergoat M, Homo-Delarche F, Giroix MH, Bailbé D, Gangnerau MN, Dolz M, Tourrel-Cuzin C, Movassat J.

Mol Cell Endocrinol. 2009 Jan 15;297(1-2):73-85. doi: 10.1016/j.mce.2008.06.013. Epub 2008 Jul 1. Review.

PMID:
18640239
[PubMed - indexed for MEDLINE]
3.

Type 2 diabetes - a matter of failing beta-cell neogenesis? Clues from the GK rat model.

Movassat J, Calderari S, Fernández E, Martín MA, Escrivá F, Plachot C, Gangnerau MN, Serradas P, Alvarez C, Portha B.

Diabetes Obes Metab. 2007 Nov;9 Suppl 2:187-95. Review.

PMID:
17919193
[PubMed - indexed for MEDLINE]
4.

[Transmitted beta-cell dysfunction as a cause for type 2-diabetes].

Portha B.

Med Sci (Paris). 2003 Aug-Sep;19(8-9):847-53. Review. French.

PMID:
14593616
[PubMed - indexed for MEDLINE]
Free Article
5.

Islet structure and function in the GK rat.

Portha B, Lacraz G, Chavey A, Figeac F, Fradet M, Tourrel-Cuzin C, Homo-Delarche F, Giroix MH, Bailbé D, Gangnerau MN, Movassat J.

Adv Exp Med Biol. 2010;654:479-500. doi: 10.1007/978-90-481-3271-3_21. Review.

PMID:
20217511
[PubMed - indexed for MEDLINE]
6.

The GK rat: a prototype for the study of non-overweight type 2 diabetes.

Portha B, Giroix MH, Tourrel-Cuzin C, Le-Stunff H, Movassat J.

Methods Mol Biol. 2012;933:125-59. doi: 10.1007/978-1-62703-068-7_9. Review.

PMID:
22893405
[PubMed - indexed for MEDLINE]
7.

Islet gene expression and function in type 2 diabetes; studies in the Goto-Kakizaki rat and humans.

Ostenson CG, Efendic S.

Diabetes Obes Metab. 2007 Nov;9 Suppl 2:180-6. Review.

PMID:
17919192
[PubMed - indexed for MEDLINE]
8.

Beta-cell failure in type 2 diabetes mellitus.

Lencioni C, Lupi R, Del Prato S.

Curr Diab Rep. 2008 Jun;8(3):179-84. Review.

PMID:
18625113
[PubMed - indexed for MEDLINE]
9.

Role of metabolic programming in the pathogenesis of beta-cell failure in postnatal life.

Simmons RA.

Rev Endocr Metab Disord. 2007 Jun;8(2):95-104. Review.

PMID:
17680370
[PubMed - indexed for MEDLINE]
10.

Defects in insulin secretion and action in the pathogenesis of type 2 diabetes mellitus.

Tripathy D, Chavez AO.

Curr Diab Rep. 2010 Jun;10(3):184-91. doi: 10.1007/s11892-010-0115-5. Review.

PMID:
20425581
[PubMed - indexed for MEDLINE]
11.

Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequences.

Lupi R, Del Prato S.

Diabetes Metab. 2008 Feb;34 Suppl 2:S56-64. doi: 10.1016/S1262-3636(08)73396-2. Review.

PMID:
18640587
[PubMed - indexed for MEDLINE]
12.

Fate of the beta-cell in the pathophysiology of type 2 diabetes.

Campbell RK.

J Am Pharm Assoc (2003). 2009 Sep-Oct;49 Suppl 1:S10-5. doi: 10.1331/JAPhA.2009.09076. Review.

PMID:
19801360
[PubMed - indexed for MEDLINE]
13.

Pancreatic beta-cells dysfunction in polycystic ovary syndrome.

Diamanti-Kandarakis E, Xyrafis X, Boutzios G, Christakou C.

Panminerva Med. 2008 Dec;50(4):315-25. Review.

PMID:
19078872
[PubMed - indexed for MEDLINE]
14.

The quest for a model of type II diabetes with nephropathy: the Goto Kakizaki rat.

Janssen U, Vassiliadou A, Riley SG, Phillips AO, Floege J.

J Nephrol. 2004 Nov-Dec;17(6):769-73. Review.

PMID:
15593049
[PubMed - indexed for MEDLINE]
15.

Protection of pancreatic beta-cells: is it feasible?

Bonora E.

Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):74-83. Review.

PMID:
18096375
[PubMed - indexed for MEDLINE]
16.

Animal models of type 2 diabetes with reduced pancreatic beta-cell mass.

Masiello P.

Int J Biochem Cell Biol. 2006;38(5-6):873-93. Epub 2005 Oct 4. Review.

PMID:
16253543
[PubMed - indexed for MEDLINE]
17.

Beta cells in type 2 diabetes - a crucial contribution to pathogenesis.

Maedler K.

Diabetes Obes Metab. 2008 May;10(5):408-20. Epub 2007 Apr 19. Review.

PMID:
17451426
[PubMed - indexed for MEDLINE]
18.

Mitochondrial dysfunction in pancreatic beta-cells in Type 2 diabetes.

Mulder H, Ling C.

Mol Cell Endocrinol. 2009 Jan 15;297(1-2):34-40. doi: 10.1016/j.mce.2008.05.015. Epub 2008 Jul 7. Review.

PMID:
18606489
[PubMed - indexed for MEDLINE]
19.

An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment.

Marchetti P, Dotta F, Lauro D, Purrello F.

Regul Pept. 2008 Feb 7;146(1-3):4-11. Epub 2007 Aug 29. Review.

PMID:
17889380
[PubMed - indexed for MEDLINE]
20.

Functional pancreatic beta-cell mass: involvement in type 2 diabetes and therapeutic intervention.

Karaca M, Magnan C, Kargar C.

Diabetes Metab. 2009 Apr;35(2):77-84. doi: 10.1016/j.diabet.2008.09.007. Epub 2009 Feb 28. Review.

PMID:
19251449
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk